Biotechnology Assets, S.A.
Research Biotechnology Assets, S.A. (BST.MC) on Bullrun: market cap EUR 14.11M. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerBST.MC
- ExchangeMC
- CountrySpain
- SectorHealthcare
- IndustryBiotechnology
- CurrencyEUR
- Market capEUR 14.11M
- Financial periodFY2025
- RevenueEUR 3.09M
- Revenue growth22.9%
- Net income-EUR 1.92M
- Free cash flow-EUR 356.04K
- Gross margin103.6%
Valuation Snapshot
latest market cap is EUR 14.11M.
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | EUR 3.09M | -EUR 1.92M | -EUR 356.04K | 103.6% | -0.03 | EUR 369.44K | EUR 4.01M | EUR 6.96M |
| FY2024 | EUR 2.51M | -EUR 2.92M | -EUR 794.57K | 105.5% | -0.04 | EUR 143.82K | EUR 5.13M | EUR 6.61M |
| FY2023 | EUR 3.60M | EUR 1.57M | -EUR 278.23K | 97.0% | 0.03 | EUR 311.12K | EUR 7.13M | EUR 6.68M |
| FY2022 | EUR 2.61M | -EUR 1.94M | -EUR 2.13M | 100.8% | -0.04 | EUR 664.26K | EUR 11.73M | EUR 4.03M |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-10-04 | EUR 14.11M | n/a | n/a | 0 |
Dividend history
Latest trailing dividend snapshot: annual dividend/share 0 EUR.
| Year | Dividends/share |
|---|---|
| FY2022 | 0.13 EUR |
About Biotechnology Assets, S.A.
Biotechnology Assets, S.A. develops and markets biotechnological assets for application in the biopharmaceutical, agrochemical, cosmetic, veterinary, and chemical industries in Spain and internationally. It offers SPLITTERA, a solution for site-specific conjugation of proteins; Click Car for Split-CARs universal connectors; VACC-ZERA, a tool to generate recombinant proteins in microparticles; and CLICK'N CUT for tag-less protein purification. The company is based in Cádiz, Spain.
Related stock research
Other Healthcare stocks
Frequently asked questions
What is Biotechnology Assets, S.A.'s market cap?
Biotechnology Assets, S.A.'s market capitalization is EUR 14.11M.
What does Biotechnology Assets, S.A. do?
Biotechnology Assets, S.A. develops and markets biotechnological assets for application in the biopharmaceutical, agrochemical, cosmetic, veterinary, and chemical industries in Spain and internationally. It offers SPLITTERA, a solution for site-specific conjugation of proteins; Click Car for Split-CARs universal connectors; VACC-ZERA, a tool to generate recombinant proteins in microparticles; and CLICK'N CUT for tag-less protein purification. The company is based in Cádiz, Spain.